"Retina Consultants of Texas provides world-class retina care to patients throughout Houston, San Antonio, and beyond. Visit our flagship retina center in Bellaire to get top retina specialist care for wet & dry macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, and more. We offer a full spectrum of retinal diagnostics (fluorescein angiography, etc.) and treatments such as eye injections (Avastin, Lucentis, Eylea), vitrectomy, and scleral buckle. Our retina research center is the largest in the country, with many cutting-edge clinical trials. Our Houston and San Antonio locations are easily accessible for patients in Cypress, Sugar Land, The Woodlands, Bellaire, New Braunfels, Kerrville, Seguin, and beyond."

During the past decade, Retina Consultants of Texas conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 5 clinical trials were completed. i.e. 18.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Texas" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Clearside Biomedical, Inc." with 2 trials sponsored and "Gyroscope Therapeutics Limited" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Texas" #1 collaborator was "Janssen Research & Development, LLC" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator, "CBCC Global Research" with 1 trials as a collaborator, "Clinical Trials Resource Group, LLC" with 1 trials as a collaborator and "InFocus Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Texas" are "Diabetic Macular Edema" (6 trials), "Geographic Atrophy" (5 trials), "Neovascular Age-related Macular Degeneration" (5 trials), "Macular Degeneration" (4 trials) and "Diabetic Retinopathy" (3 trials). Many other conditions were trialed in "Retina Consultants of Texas" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Texas" are "Drug" (27 trials), "Biological" (5 trials), "Other" (5 trials), "Procedure" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "CLS-AX" (2 trials) and "Galegenimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Texas" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Texas". undefined are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Retina Consultants of Texas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Texas, 8 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".